Literature DB >> 17617035

Within-subject variation of plasma resistin levels over a 1-year period.

Cornelia Weikert1, Sabine Westphal, Claus Luley, Stefan N Willich, Heiner Boeing, Tobias Pischon.   

Abstract

BACKGROUND: Resistin, a recently discovered hormone, is purportedly involved in metabolic and inflammatory processes in humans and may thus be an important marker to assess disease risk in large-scale epidemiological studies.
METHODS: We assessed the reliability of human resistin levels in 63 men and 51 women aged 35-67 years with repeated measurements of resistin over a period of 1 year. Student's paired t-test was used to compare resistin concentrations at baseline and 1 year later. Intraclass correlation coefficients (ICCs) were calculated by analysis of variance.
RESULTS: There was no significant difference between resistin concentrations at baseline and after 1 year for both sexes combined or when analyzed separately for men and women. The ICCs were 0.70 (95% CI 0.59-0.78) for both sexes combined, 0.75 (95% CI 0.62-0.84) for men, and 0.66 (95% CI 0.47-0.79) for women. Resistin levels were not significantly related to age, body mass index, waist-to-hip ratio, sex, or fasting status.
CONCLUSIONS: Individual blood resistin concentrations did not significantly change over a period of 1 year, but showed a high degree of reliability. Our findings suggest that a single resistin measurement may be sufficient for risk assessment in epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617035     DOI: 10.1515/CCLM.2007.148

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  5 in total

1.  Plasma resistin levels associate with risk for hypertension among nondiabetic women.

Authors:  Luxia Zhang; Gary C Curhan; John P Forman
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

Review 2.  Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.

Authors:  Giovanni Lombardi; Mosè Barbaro; Massimo Locatelli; Giuseppe Banfi
Journal:  Endocrine       Date:  2017-02-08       Impact factor: 3.633

3.  Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.

Authors:  Faina Linkov; Yian Gu; Alan A Arslan; Mengling Liu; Roy E Shore; Lyudmila Velikokhatnaya; Karen L Koenig; Paolo Toniolo; Adele Marrangoni; Zoya Yurkovetsky; Anne Zeleniuch-Jacquotte; Anna E Lokshin
Journal:  Eur Cytokine Netw       Date:  2009-03       Impact factor: 2.737

4.  Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach.

Authors:  Anna Floegel; Dagmar Drogan; Rui Wang-Sattler; Cornelia Prehn; Thomas Illig; Jerzy Adamski; Hans-Georg Joost; Heiner Boeing; Tobias Pischon
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

5.  Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.

Authors:  Claudia Menzaghi; Simonetta Bacci; Lucia Salvemini; Christine Mendonca; Giuseppe Palladino; Andrea Fontana; Concetta De Bonis; Antonella Marucci; Elizabeth Goheen; Sabrina Prudente; Eleonora Morini; Stefano Rizza; Alyssa Kanagaki; Grazia Fini; Davide Mangiacotti; Massimo Federici; Salvatore De Cosmo; Fabio Pellegrini; Alessandro Doria; Vincenzo Trischitta
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.